Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease: a prospective observational study

References

• Miller LJ. Gastrointestinal hormones and receptors. In Yamada T, Alpers DH, Kalloo AN, Kaplowitz N, Owyang C, Powell DW, editors. Textbook of gastroenterology. 5th edn. Philadelphia, PA: Lippincott-Williams and Wilkins; 2009. pp 56–85.
   Google Scholar
• Schonhoff SE, Giel-Moloney M, Leiter AB. Minireview: development and differentiation of gut endocrine cells. Endocrinology 2004;145:2639–44.
   PubMed Web of Science ®Google Scholar
• Huttner WB, Gerdes HH, Rosa P. The granin (chromogranin/secretogranin) family. Trends Biochem Sci 1991;16:27–31.
   PubMed Web of Science ®Google Scholar
• Helle K. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biol Rev Camb Philos Soc 2004;79:769–94.
   PubMed Web of Science ®Google Scholar
• Laurent Taupenot L, Harper KL, O’Connor DT. The chromogranin–secretogranin family. N Engl J Med 2003;348:1134–49.
   PubMed Web of Science ®Google Scholar
• O’Connor DT, Deftos LJ. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986;314:1145–51.
   PubMed Web of Science ®Google Scholar
• Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol 2010;161:19–27.
   PubMed Web of Science ®Google Scholar
• Ferrero E, Magni E, Curnis F, Villa A, Ferrero ME, Corti A. Regulation of endothelial cell shape and barrier function by chromogranin A. Ann N Y Acad Sci 2002;971:355–8.
   PubMed Web of Science ®Google Scholar
• Sidhu R, McAlindon ME, Leeds JS, Skilling J, Sanders DS. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome. J Gastrointestin Liver Dis 2009;18:23–6.
   PubMed Web of Science ®Google Scholar
• Sciola V, Massironi S, Conte D, Caprioli F, Ferrero S, Ciafardini C, et al. Plasma chromogranin A in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:867–71.
   PubMed Web of Science ®Google Scholar
• Granberg D, Stridsberg M, Seensalu R, Eriksson B, Lundqvist G, Oberg K, et al. Plasma chromogranin A in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1999;84:2712–17.
   PubMed Web of Science ®Google Scholar
• Spadaro A, Ajello A, Morace C, Zirilli A, D’arrigo G, Luigiano C, et al. Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. World J Gastroenterol 2005;11:1987–90.
   PubMed Web of Science ®Google Scholar
• Sidhu R, Drew K, McAlindon ME, Lobo AJ, Sanders DS. Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis? Inflamm Bowel Dis 2009;16:361.
   Web of Science ®Google Scholar
• Strid H, Simrén M, Lasson A, Isaksson S, Stridsberg M, Öhman L. Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity. J Crohns Colitis 2013;7:615–22.
   Google Scholar
• Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 2012;6:991–1030.
   PubMed Web of Science ®Google Scholar
• Ferrante M, Karmiris K, Newnham E, Siffledeen J, Zelinkova Z, van Assche G, et al. Physician perspectives on unresolved issues in the use of conventional therapy in Crohn’s disease: results from an international survey and discussion programme. J Crohns Colitis 2012;6:116–31.
   PubMed Web of Science ®Google Scholar
• Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B, et al. Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality. Eur Heart J 2002;23:967–74.
   PubMed Web of Science ®Google Scholar
• Hsiao RJ, Mezger MS, O’Connor DT. Chromogranin A in uremia: progressive retention of immunoreactive fragments. Kidney Int 1990;37:955–64.
   PubMed Web of Science ®Google Scholar
• Massironi S, Fraquelli M, Paggi S, Sangiovanni A, Conte D, Sciola V, et al. Chromogranin A levels in chronic liver disease and hepatocellular carcinoma. Dig Liver Dis 2009;41:31–5.
   PubMedGoogle Scholar
• Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JH, Parmer RJ, O’Connor DT. Chromogranin A. Storage and release in hypertension. Hypertension 1990;15:237–46.
   PubMed Web of Science ®Google Scholar
• Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, et al. Serum gastrin and chromogranin A during medium and long term acid suppressive therapy: a case-control study. Aliment Pharmacol Ther 1999;13:145–53.
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480–91.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955;2:1041–8.
   PubMed Web of Science ®Google Scholar
• Best WR, Becktel J, Singleton J, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 1976;70:439–44.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohns Colitis 2010;4:7–27.
   PubMed Web of Science ®Google Scholar
• Dignass A, van Assche G, Lindsay JO, Lémann M, Söderholm J, Colombel JF, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis 2010;4:28–62.
   PubMed Web of Science ®Google Scholar
• Moran GW, Pennock J, McLaughlin JT. Enteroendocrine cells in terminal ileal Crohn’s disease. J Crohns Colitis 2012;6:871–80.
   PubMed Web of Science ®Google Scholar
• Stenson WF, Snapper SB. Challenges in IBD research: assessing progress and rethinking the research agenda. Inflamm Bowel Dis 2008;14:687–708.
   PubMed Web of Science ®Google Scholar
• Corti A, Ferrari R, Ceconi C. Chromogranin A and tumor necrosis factor-alpha (TNF) in chronic heart failure. Adv Exp Med Biol 2000;482:351–9.
   PubMed Web of Science ®Google Scholar
• Ferrero E, Scabini S, Magni E, Foglieni C, Belloni D, Colombo B, et al. Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J 2004;18:554–6.
   PubMed Web of Science ®Google Scholar
• Portela-Gomes GM, Grimelius L, Wilander E, Stridsberg M. Granins and granin-related peptides in neuroendocrine tumours. Regul Pept 2010;165:12–20.
   PubMedGoogle Scholar
• Di Comite G, Marinosci A, Di Matteo P, Manfredi A, Rovere-Querini P, Baldissera E, et al. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. Ann N Y Acad Sci 2006;1069:428–37.
   PubMed Web of Science ®Google Scholar
• Di Comite G, Rossi CM, Marinosci A, Lolmede K, Baldissera E, Aiello P, et al. Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation. J Leukoc Biol 2009;85:81–7.
   PubMed Web of Science ®Google Scholar
• Rumio C, Dusio GF, Colombo B, Gasparri A, Cardani D, Marcucci F, et al. The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration. Dig Dis Sci 2012;57:1227–37.
   PubMed Web of Science ®Google Scholar
• Rozansky DJ, Wu H, Tang K, Parmer RJ, O’Connor DT, et al. Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element. J Clin Invest 1994;94:2357–68.
   PubMed Web of Science ®Google Scholar